Cite
HARVARD Citation
Serfling, S. et al. (2022). Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor–Directed Molecular Imaging and Therapy. Clinical nuclear medicine. pp. 512-516. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Serfling, S. et al. (2022). Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor–Directed Molecular Imaging and Therapy. Clinical nuclear medicine. pp. 512-516. [Online].